RENEO PHARMACEUTICALS INC's ticker is RPHM and the CUSIP is 75974E103. A total of 33 filers reported holding RENEO PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $25,344,169 | +16.0% | 3,330,377 | 0.0% | 1.87% | +11.0% |
| Q2 2023 | $21,847,273 | +6.5% | 3,330,377 | -2.9% | 1.69% | +24.8% |
| Q1 2023 | $20,513,654 | +156.7% | 3,430,377 | 0.0% | 1.35% | +171.1% |
| Q4 2022 | $7,992,778 | -30.4% | 3,430,377 | 0.0% | 0.50% | -8.9% |
| Q3 2022 | $11,492,000 | +26.4% | 3,430,377 | 0.0% | 0.55% | +22.3% |
| Q2 2022 | $9,090,000 | -9.9% | 3,430,377 | 0.0% | 0.45% | -15.8% |
| Q1 2022 | $10,085,000 | -65.6% | 3,430,377 | 0.0% | 0.53% | -61.7% |
| Q4 2021 | $29,330,000 | +14.8% | 3,430,377 | 0.0% | 1.39% | +5.1% |
| Q3 2021 | $25,556,000 | -20.1% | 3,430,377 | 0.0% | 1.32% | -6.9% |
| Q2 2021 | $32,005,000 | – | 3,430,377 | – | 1.42% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RiverVest Venture Management LLC | 2,409,220 | $8,071,000 | 9.37% |
| Abingworth LLP | 2,073,957 | $6,948,000 | 2.38% |
| Aisling Capital Management LP | 886,075 | $2,968,000 | 1.97% |
| NEA Management Company, LLC | 4,786,921 | $16,036,000 | 0.80% |
| Novo Holdings A/S | 3,430,377 | $11,492,000 | 0.55% |
| Ikarian Capital, LLC | 155,819 | $521,000 | 0.10% |
| Rock Springs Capital Management LP | 1,143,185 | $3,830,000 | 0.10% |
| Ergoteles LLC | 37,640 | $126,000 | 0.00% |
| MAI Capital Management | 63,210 | $212,000 | 0.00% |
| RBF Capital, LLC | 14,536 | $49,000 | 0.00% |